An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer

scientific article

An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JURO.2007.01.134
P698PubMed publication ID17509305

P50authorSteven J FrankQ61160397
Deborah KubanQ109303827
P2093author name stringJohn Davis
Andrew K Lee
Louis L Pisters
Roland Bassett
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectiodineQ1103
brachytherapyQ896687
prostate cancerQ181257
adaptive radiation therapyQ180507
iodine in medicineQ28196266
P304page(s)2151-6; discussion 2156
P577publication date2007-06-01
P1433published inJournal of UrologyQ15709979
P1476titleAn assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
P478volume177

Reverse relations

cites work (P2860)
Q37477409125I Radioactive Seeds Implantation Therapy for Hepatocellular Carcinoma
Q36388719A Bayesian nonrigid registration method to enhance intraoperative target definition in image-guided prostate procedures through uncertainty characterization
Q37767397A review of low-dose-rate prostate brachytherapy--techniques and outcomes
Q84960767Acute bowel morbidity after prostate brachytherapy with cesium-131
Q84565126Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131
Q44198117Can high-dose-rate brachytherapy prevent the major genitourinary complication better than external beam radiation alone for patients with previous transurethral resection of prostate?
Q35556781Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers
Q64950302Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer.
Q82498035Conservation of Erectile Function following Brachytherapy for Low-Risk Prostate Cancer
Q33885592Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing
Q36048698Difference in the rate of rectal complications following prostate brachytherapy based on the prostate-rectum distance and the prostate longitudinal length among early prostate cancer patients
Q47317738Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer
Q50682319Evaluation of health-related quality of life in patients with prostate cancer after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
Q34795596Evidence-based guideline recommendations on low-dose rate brachytherapy in patients with low- or intermediate-risk prostate cancer
Q47814066Experiences and psychological distress of spouses of prostate cancer patients at time of diagnosis and primary treatment.
Q38217667Failure to address potential bias in non-randomised controlled clinical trials may cause lack of evidence on patient-reported outcomes: a method study
Q64327864Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients
Q50088072Fully automatic deformable registration of pretreatment MRI/CT for image-guided prostate radiotherapy planning
Q90247628Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study
Q48570381Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study
Q37300111Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy
Q38863898Hypofractionated radiotherapy for organ-confined prostate cancer: is less more?
Q48407978Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy
Q38943718Improvement of severe baseline lower urinary tract symptoms following robotic-assisted laparoscopic prostatectomy
Q37402652Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management
Q38754823Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade.
Q40732738Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer
Q24235544Low-dose rate brachytherapy for men with localized prostate cancer
Q35079338Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer: A systematic review
Q30386046Near-infrared fluorescence imaging platform for quantifying in vivo nanoparticle diffusion from drug loaded implants.
Q37074954Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification
Q51021374Outcomes after prostate brachytherapy are even better than predicted.
Q53099080Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy.
Q91713571Particle therapy for prostate cancer: The past, present and future
Q43824418Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial
Q47982004Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey
Q36328572Physical and psychosocial side-effects of brachytherapy: a questionnaire survey.
Q40054180Presentation, management, and outcomes of complications following prostate cancer therapy
Q37766754Prostate cancer prevention: concepts and clinical recommendations
Q87508347Prostate cancer: predicting high-risk prostate cancer-a novel stratification tool
Q37686901Quality of Life and Sexual Health in the Aging of PCa Survivors
Q34413524Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study
Q83444422Quality of life among men with prostate cancer in rural Georgia
Q33845930Quality of life two years after radical prostatectomy, prostate brachytherapy or external beam radiotherapy for clinically localised prostate cancer: the Catalan Institute of Oncology/Bellvitge Hospital experience.
Q42182229Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression
Q83863906Radical retropubic prostatectomy versus brachytherapy for low-risk prostatic cancer: a prospective study
Q34315605Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials
Q36355814Risk factors for rectal bleeding associated with I-125 brachytherapy for prostate cancer
Q48064608Sexual potency preservation and quality of life after prostate brachytherapy and low-dose tadalafil
Q37118441State-of-the-art: prostate LDR brachytherapy
Q51840365The natural history of voiding function after robot-assisted laparoscopic radical prostatectomy.
Q38893692Urinary continence recovery after radical prostatectomy - anatomical/reconstructive and nerve-sparing techniques to improve outcomes.
Q84201965Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
Q82740496[Quality of life after localized prostate cancer treatment]
Q85273029[Sexuality and prostate cancer]

Search more.